与患有1型糖尿病的儿童和青少年血糖控制相关的饮食因素
Sara Zakarneh1, Yasmin Khial2, Reema Tayyem2
1Department of Nutrition & Food Technology, Faculty of Agriculture, The University of Jordan, Amman, 11942, Jordan.
Current pediatric reviews
|August 23, 2023
概括
年轻人1型糖尿病的管理包括饮食,运动和了解营养. 本综述探讨了肥胖,遗传和体力活动等因素如何影响T1DM儿童和青少年的血糖控制.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 代谢障碍 代谢障碍 代谢障碍
- 营养科学 营养科学
背景情况:
- 1型糖尿病 (T1DM) 是一种自身免疫性疾病,导致儿童胰岛素缺乏和高血糖.
- 它的患病率很高,每300名美国儿童中就有1名患病,全球发病率正在上升.
- 有效的T1DM管理需要胰岛素治疗,饮食调整,运动和营养知识.
研究的目的:
- 审查生活方式,遗传和环境因素与儿科T1DM中的血糖控制之间的复杂关系.
- 综合当前关于饮食,体育活动和肥胖如何影响青少年T1DM管理的证据.
主要方法:
- 在PubMed,ScienceDirect和Embase数据库中进行了全面的文献搜索.
- 分析了2004年12月至2022年4月的出版物.
- 关键搜索词包括T1DM,儿童,青少年,肥胖,营养素,饮食模式,体育活动和遗传学.
主要成果:
- 饮食因素,包括宏观营养素和微量营养素摄入量,显著影响血糖控制.
- 身体活动水平和肥胖状况是T1DM中血糖调节的关键决定因素.
- 遗传倾向和环境影响也在疾病管理中起作用.
结论:
- 在儿科T1DM中优化血糖控制需要采取多方面的方法,包括营养,体力活动和体重管理.
- 对遗传学和环境因素的相互作用进行进一步的研究对于青少年和儿童个性化T1DM护理至关重要.
- 了解这些因素可以为患有T1DM的儿童和青少年制定更好的治疗策略.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Insulin: Dosing Regimen and Adverse Effects
205
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205
Diabetes: Management and Pharmacotherapy
310
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
310
Diabetes: Symptoms, Diagnosis, and Complications
588
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
588
Hypoglycemia and Glucagon
296
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
296


